The HSV-2 vaccine missed its primary endpoint in the Phase II study of annualized lesion recurrence rate
Testa Center focuses on advancing manufacturing capabilities and the commercialization of new technologies in life sciences, aligning with Sweden's goals of strengthening its capacity for innovation and thus its economic competitiveness.
While cancer immunotherapy is one of the most exciting new research areas due to the potential it holds for treating tumors that have been...
Researchers have created a vaccine that protects against malaria infection in mouse models, paving the way for the development of a human vaccine that works by targeting the specific protein that parasites use to evade the immune system
With the approval, SIGA said, it is entitled to a $41 million payment under its a $472M contract with the U.S. Department of Health and Human Services’ Biomedical Advanced Research and Development Authority (BARDA), which joined SIGA in developing the treatment.
The world’s largest two markets for prescription medicines remain a study in contrasts: The European Medicines Agency authorizes 11 biosimilar drugs for market in the nations comprising the EU. Meanwhile in the U.S., the FDA continues to ponder draft guidances for how the agency will evaluate biosimilars.
Researchers in Europe and Australia have developed an anti-obesity “chemical cigarette” that exploits the body’s natural responses to both cold exposure and smoking. The...
Firm will build VLP vaccine manufacturing plant and will also develop flu vaccines for other emerging markets.
Negative rapid test results may delay antiviral therapy in patients with severe influenza
Please wait while you are redirected to the right page...